Biblio

Author Title [ Type(Desc)] Year
Filters: Author is Marolleau, Jean-Pierre  [Clear All Filters]
Journal Article
Ivanoff S, Gruson B, Chantepie SP, Lemasle E, Merlusca L, Harrivel V, Charbonnier A, Votte P, Royer B, Marolleau J-P. 5-azacytidine treatment for relapsed or refractory acute myeloid leukemia after intensive chemotherapy. Am J Hematol. 2013.
Naudot M, Garcia AGarcia, Jankovsky N, Barre A, Zabijak L, Azdad SZakaria, Collet L, Bedoui F, Hébraud A, Schlatter G, et al. The combination of a poly-caprolactone/nano-hydroxyapatite honeycomb scaffold and mesenchymal stem cells promotes bone regeneration in rat calvarial defects. J Tissue Eng Regen Med. 2020.
Caulier A, Roussel M, Morel P, Lombion N, Branco B, Galtier J, Hulin C, Perrot A, Richez V, Michaud-Robert A-V, et al. EPIDEMIOLOGICAL LANDSCAPE OF YOUNG MULTIPLE MYELOMA PATIENTS DIAGNOSED EARLIER THAN 40 YEARS: THE FRENCH EXPERIENCE. Blood. 2021.
Younan N, Soussain C, Choquet S, Cassoux N, Touitou V, Schmitt A, Chinot O, Obéric L, Damaj G, Houot R, et al. Isolated intraocular relapses of primary cerebral lymphomas: AN LOC NETWORK STUDY. Hematol Oncol. 2022.
Crahès M, Bories M-C, Viquin J-T, Marolleau J-P, Desnos M, Larghero J, Soulat G, Bruneval P, Hagège AA, Menasché P. Long-Term Engraftment (16 Years) of Myoblasts in a Human Infarcted Heart. Stem Cells Transl Med. 2018.
Bouvier A, Hamel J-F, Delaunay J, Delabesse E, Dumas P-Y, Ledoux MPierre, Peterlin P, Luquet I, Guepin GRoth, Bulabois CEric, et al. Molecular classification and prognosis in younger adults with acute myeloid leukemia patients and intermediate-risk cytogenetics treated or not by gemtuzumab ozogamycin: final results of the GOELAMS/FILO AML 2006-IR trial. Eur J Haematol. 2021.
Lebon D, Collet L, Djordjevic S, Gomila C, Ouled-Haddou H, Platon J, Demont Y, Marolleau J-P, Caulier A, Garçon L. PIEZO1 is essential for the survival and proliferation of acute myeloid leukemia cells. Cancer Med. 2024;13(2):e6984.